26 Sep 2022

It’s been a lifelong dream to run the London Marathon

Ralph Windle was a well-known poet, author, academic, former CEO of Nabisco UK, and commentator on the arts and science. For many his most memorable creation was the character of Bertie Ramsbottom, a sheep with a sense of humour. Ralph had his last letter published in the Guardian at the age of 87.

Ralph, who lived in Oxfordshire, died in 2019 when 88. He had been diagnosed a few years before with Myelofibrosis, an uncommon type of bone marrow cancer that disrupts the body’s normal production of blood cells. His only symptoms had been fatigue and gout.

Sonya Bedi is married to Ralph’s son, Justin. She lives in Crystal Palace, south London.

“Ralph was a wonderful and loving man, a great father, grandfather and great-grandfather,” said Sonya, “as well as being an internationally successful business consultant and a noted satirical poet, conversationalist and man of letters. This was the first time cancer touched the life of someone in my family – and it has since opened my eyes to just how many stories of diagnosis, treatments, survival and loss there are around us.”

During his illness, Ralph was treated at the John Radcliffe hospital in Oxford by blood cancer specialist Professor Adam Mead as part of a trial program of experimental treatment and new research. The treatment worked well for a few years but sadly the medication eventually stopped controlling his red blood cell count.

In 2022 Sonya decided to run the London Marathon to raise money for Leukaemia UK in memory of Ralph.

Sonya, 40, said: “It’s been a lifelong dream to run the London Marathon. I’m especially proud of myself as I have two young children, aged three and one, which can make carving time out to train a challenge! However, I have just completed my longest training run of 20 miles, and am slowing down now before the big day on October 2nd. I am really looking forward to taking in the celebratory atmosphere, running past the iconic London landmarks that I love, and hopefully hearing lots of cheering along the way. I love the discipline and power of running and it suits me well as I am a very goal-oriented person who craves alone time more and more as I get older!”

“I’m running and fundraising for Leukaemia UK because I want to contribute something to help advance their incredible research that can create kinder and more effective treatments for leukaemia.”

Read further inspiring fundraising stories, including Esther’s half marathon journey.

Read more stories from our community.

Related posts

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

20 October 2023

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…

Leukaemia UK announced as one of five charities for star-studded event Shall We Dance? with Dame Arlene Phillips and Anton Du Beke

26 October 2021

Leukaemia UK announced as one of five charities for star-studded event Shall We Dance? with Dame Arlene Phillips and Anton Du Beke

Leukaemia UK is delighted to have been announced as one of five charities for whom the proceeds of a new star-studded dance event, Shall We Dance?, will go towards when it takes place next year.

Leukaemia UK is looking for volunteers for their Patient Experience Advisory Panel

4 June 2022

Leukaemia UK is looking for volunteers for their Patient Experience Advisory Panel

Leukaemia UK is committed to championing advancements in better treatments and care for all. We want to ensure the needs of patients are at the heart of everything we do, and that the voices of people affected by leukaemia and related conditions are being heard. That is why we are setting up a Patient Experience Advisory Panel.

Can the unique differences between stem cells tell us how well CML treatment will work?

22 May 2023

Can the unique differences between stem cells tell us how well CML treatment will work?

What if we could predict how chronic myeloid leukaemia (CML) patients will respond to treatment? Could the unique signatures of CML stem cells hold the key to personalising treatment for…